Joseph C. Papa
2018 - Valeant Pharmaceuticals International
Compensation breakdown
Non-Equity Incentive Plan | $3,802,500 |
---|---|
Option Awards | $1,999,715 |
Salary | $1,500,000 |
Stock Awards | $7,344,927 |
Other | $93,908 |
Total | $14,741,050 |
Papa received $7.3M in stock awards, accounting for 50% of the total pay in 2018.
Papa also received $3.8M in non-equity incentive plan, $2M in option awards, $1.5M in salary and $93.9K in other compensation.
Rankings
In 2018, Joseph C. Papa's compensation ranked 324th out of 14,244 executives tracked by ExecPay. In other words, Papa earned more than 97.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 324 | 98th |
Manufacturing | 113 | 98th |
Chemicals And Allied Products | 34 | 98th |
Drugs | 28 | 99th |
Pharmaceutical Preparations | 20 | 99th |
Pay ratio
Joseph C. Papa's Pay | $14,741,050 |
---|---|
Median Employee's Pay | $37,872 |
Pay Ratio | 389to 1 |
In 2018, the annual total compensation of Joseph C. Papa was $14,741,050.
The annual total compensation of the median employee at Valeant Pharmaceuticals International was $37,872.
The ratio of Joseph C. Papa's pay to the pay of median employee was therefore 389 to one.
Papa's colleagues
We found four more compensation records of executives who worked with Joseph C. Papa at Valeant Pharmaceuticals International in 2018.
2018
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
2018
Thomas Appio
Valeant Pharmaceuticals International
President & Co, Head, Bausch + Lomb/International
2018
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
2018
Joseph Gordon
Valeant Pharmaceuticals International